PFS
VRTX icon

Prospera Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Prospera Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Buy
2,571
+211
+9% +$93.5K 0.02% 671
2026
Q1 		$1.05M Buy
2,360
+75
+3% +$35K 0.02% 689
2025
Q4 		$1.04M Buy
2,285
+52
+2% +$22.4K 0.02% 659
2025
Q3 		$875K Sell
2,233
-8,002
-78% -$3.34M 0.01% 726
2025
Q2 		$4.56M Buy
10,235
+7,204
+238% +$3.32M 0.08% 241
2025
Q1 		$1.47M Sell
3,031
-271
-8% -$126K 0.03% 456
2024
Q4 		$1.33M Sell
3,302
-10,196
-76% -$4.73M 0.03% 468
2024
Q3 		$6.28M Buy
13,498
+10,951
+430% +$5.26M 0.16% 141
2024
Q2 		$1.19M Sell
2,547
-196
-7% -$85.1K 0.03% 461
2024
Q1 		$1.15M Buy
2,743
+125
+5% +$52.8K 0.03% 462
2023
Q4 		$1.07M Sell
2,618
-51
-2% -$18.8K 0.04% 456
2023
Q3 		$928K Buy
2,669
+38
+1% +$13.3K 0.04% 433
2023
Q2 		$926K Buy
2,631
+4
+0.2% +$1.35K 0.04% 438
2023
Q1 		$828K Buy
2,627
+65
+3% +$19.5K 0.03% 479
2022
Q4 		$740K Buy
2,562
+87
+4% +$26.5K 0.04% 434
2022
Q3 		$716K Buy
2,475
+230
+10% +$66.2K 0.04% 442
2022
Q2 		$633K Buy
2,245
+566
+34% +$151K 0.03% 462
2022
Q1 		$438K Buy
+1,679
New +$398K 0.02% 636
2020
Q4 		– Sell
-157
Closed -$43K – 1556
2020
Q3 		$43K Sell
157
-535
-77% -$148K 0.02% 674
2020
Q2 		$201K Buy
+692
New +$188K 0.02% 538

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Prospera Financial Services's VRTX Position: Q2 2026 in Review

Prospera Financial Services increased its Vertex Pharmaceuticals (VRTX) stake by 8.9% in Q2 2026, buying an estimated $93.5K and bringing the position to 2,571 shares worth $1.28M. The position accounts for 0.02% of the portfolio, ranked #671.

Prospera Financial Services first reported a position in VRTX in Q2 2020 and has held it in 20 quarters since. The position peaked at $6.28M in Q3 2024. 327 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Prospera Financial Services held 2,571 shares of Vertex Pharmaceuticals worth $1.28M as of Q2 2026.
  • Prospera Financial Services bought 211 Vertex Pharmaceuticals shares in Q2 2026, an estimated $93.5K.
  • Vertex Pharmaceuticals made up 0.02% of Prospera Financial Services's portfolio in Q2 2026, its #671 holding.
  • Prospera Financial Services first reported a position in Vertex Pharmaceuticals in Q2 2020 and has held it in 20 quarters since.
  • Prospera Financial Services's Vertex Pharmaceuticals position peaked at $6.28M in Q3 2024.
  • 327 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.